CLC number:
On-line Access: 2022-03-09
Received: 2021-06-18
Revision Accepted: 2021-09-08
Crosschecked: 0000-00-00
Cited: 0
Clicked: 2859
Citations: Bibtex RefMan EndNote GB/T7714
Guosen ZHANG, Qiang WANG, Xinlei QI, Huimin YANG, Xiaodong SU, Manman YANG, Chao JIANG, Yang AN, Hong ZHENG, Lu ZHANG, Wan ZHU, Jiancheng GUO, Xiangqian GUO. OShnscc: a novel user-friendly online survival analysis tool for head and neck squamous cell carcinoma based on RNA expression profiles and long-term survival information[J]. Journal of Zhejiang University Science B,in press.Frontiers of Information Technology & Electronic Engineering,in press.https://doi.org/10.1631/jzus.B2100512 @article{title="OShnscc: a novel user-friendly online survival analysis tool for head and neck squamous cell carcinoma based on RNA expression profiles and long-term survival information", %0 Journal Article TY - JOUR
OShnscc:一个基于表达谱数据及其长期生存信息开发的头颈鳞癌在线生存分析工具创新点:本研究开发的OShnscc是目前为止包含头颈鳞癌预后数据集最多、样本量最大的在线生存分析工具。用户不仅可以在多个独立数据集中分析和比较基因的预后价值,还可以利用多种临床因素如肿瘤TNM分期、肿瘤分级、年龄、性别等因素作为筛选条件进行亚组预后分析。 方法:OShnscc的开发包括三部分:(1)以样本为人头颈鳞癌临床样本的基因芯片或二代测序数据且数据集样本数大于20个为筛选标准,从公共癌症数据库中收集和筛选有效的头颈鳞癌数据集;(2)使用SQL Server 2008对样本头颈鳞癌表达谱数据与样本生存时间进行回归分析,构建头颈鳞癌预后数据库;(3)采用Java语言开发在线分析系统,使用R语言进行生存分析,应用R sever服务进行Java语言与R语言的连接。 结论:OShnscc是一个公开免费的在线生存分析工具(网址:http://bioinfo.henu.edu.cn/HNSC/HNSCList.jsp),为缺少生物信息学背景的医学及相关科研人员提供一个快速分析基因mRNA表达量与头颈鳞癌患者预后关系的平台,有助于推动头颈鳞癌的预后标志物开发。 关键词组: Darkslateblue:Affiliate; Royal Blue:Author; Turquoise:Article
Reference[1]FauziFH, HamzanNI, RahmanNA, et al., 2020. Detection of human papillomavirus in oropharyngeal squamous cell carcinoma. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 21(12):961-976. [2]HanavadiS, MartinTA, WatkinsG, et al., 2006. Expression of interleukin 11 and its receptor and their prognostic value in human breast cancer. Ann Surg Oncol, 13(6):802-808. [3]JouA, HessJ, 2017. Epidemiology and molecular biology of head and neck cancer. Oncol Res Treat, 40(6):328-332. [4]KimKY, McShaneLM, ConleyBA, 2014. Designing biomarker studies for head and neck cancer. Head Neck, 36(7):1069-1075. [5]LiuJF, LichtenbergT, HoadleyKA, et al., 2018. An integrated TCGA Pan-Cancer Clinical Data Resource to drive high-quality survival outcome analytics. Cell, 173(2):400-416.e11. [6]NaghaviAO, EchevarriaMI, StromTJ, et al., 2016. Treatment delays, race, and outcomes in head and neck cancer. Cancer Epidemiol, 45:18-25. [7]NagyÁ, LánczkyA, MenyhártO, et al., 2018. Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets. Sci Rep, 8:9227. [8]PaiSI, WestraWH, 2009. Molecular pathology of head and neck cancer: implications for diagnosis, prognosis, and treatment. Annu Rev Pathol, 4:49-70. [9]PanD, XuL, LiuHO, et al., 2015. High expression of interleukin-11 is an independent indicator of poor prognosis in clear-cell renal cell carcinoma. Cancer Sci, 106(5):592-597. [10]PolanskaH, RaudenskaM, GumulecJ, et al., 2014. Clinical significance of head and neck squamous cell cancer biomarkers. Oral Oncol, 50(3):168-177. [11]SungH, FerlayJ, SiegelRL, et al., 2021. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 71(3):209-249. [12]TangZF, LiCW, KangBX, et al., 2017. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res, 45(W1):W98-W102. [13]WichmannG, RosolowskiM, KrohnK, et al., 2015. The role of HPV RNA transcription, immune response-related gene expression and disruptive TP53 mutations in diagnostic and prognostic profiling of head and neck cancer. Int J Cancer, 137(12):2846-2857. [14]XuDH, ZhuZW, WakefieldMR, et al., 2016. The role of IL-11 in immunity and cancer. Cancer Lett, 373(2):156-163. [15]XuN, DongRN, LinTT, et al., 2021. Development and validation of novel biomarkers related to M2 macrophages infiltration by weighted gene co-expression network analysis in prostate cancer. Front Oncol, 11:634075. [16]ZhangGS, WangQ, YangMS, et al., 2019. OSblca: a web server for investigating prognostic biomarkers of bladder cancer patients. Front Oncol, 9:466. [17]ZhaoM, LiuY, LiuR, et al., 2018. Upregulation of IL-11, an IL-6 family cytokine, promotes tumor progression and correlates with poor prognosis in non-small cell lung cancer. Cell Physiol Biochem, 45(6):2213-2224. Journal of Zhejiang University-SCIENCE, 38 Zheda Road, Hangzhou
310027, China
Tel: +86-571-87952783; E-mail: cjzhang@zju.edu.cn Copyright © 2000 - 2024 Journal of Zhejiang University-SCIENCE |
Open peer comments: Debate/Discuss/Question/Opinion
<1>